EGFR Mutational Analysis (Lung (8th 2018-2024))

EGFR Mutational Analysis (Lung (8th 2018-2024))

Organization

Field Name

ID#

ID Name

Required

Organization

Field Name

ID#

ID Name

Required

KCR

EGFR Mutational Analysis

34128

EgfrMutationalAnalysis

yes 

SEER

EGFR Mutational Analysis

3939

egfrMutationalAnalysis

yes 

Note 1 Effective years

  • This SSDI is effective for diagnosis years 2021+

  • For cases diagnosed 2018-2020, this SSDI must be blank

Note 2 Physician Statement

  • Physician statement of EGFR can be used to code this data item when no other information is available.

Note 3 Applicable histologies/stages

  • EGFR may be recorded for all histologies and stages; however, it is primarily performed for advanced non-small cell carcinomas. If information is not available, code 9.

Note 4 Neoadjuvant Therapy

  • Record the assay from tumor specimens prior to neoadjuvant therapy.

  • If neoadjuvant therapy is given and there are no EGFR results from pre-treatment specimens, report the findings from post-treatment specimens.

Code

Description

Code

Description

0

Normal
EGFR negative, EGFR wild type
Negative for mutations, no alterations, no mutations (somatic) identified, not present, not detected

1

Abnormal (mutated)/detected in exon(s) 18, 19, 20, and/or 21

2

Abnormal (mutated)/detected but not in exon(s) 18, 19, 20, and/or 21

4

Abnormal (mutated)/detected, NOS, exon(s) not specified

7

Test ordered, results not in chart

8

Not applicable: Information not collected for this case
(If this information is required by your standard setter, use of code 8 may result in an edit error.)

9

Not documented in medical record
EGFR not assessed or unknown if assessed

<BLANK>

Must be blank if diagnosis year is before 2021

Related content